Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01562769
Other study ID # 2011-A01360-41
Secondary ID LOC/11-20
Status Terminated
Phase N/A
First received March 22, 2012
Last updated August 20, 2015
Start date March 2012
Est. completion date June 2015

Study information

Verified date May 2015
Source Rennes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
Study type Observational

Clinical Trial Summary

Application of isolation (=contact precautions) in hospitalized patients is recommended when patient is colonized (or infected) by micro-organism known for its outbreak capacity or high pathogenicity. It allows the reinforcement of universal precautions (=standard precautions) in order to control patient-to-patient micro-organisms transmission. Recently, the efficacy of this measure is questioned and its impact on patient care seems deleterious.

In a particular context of Infectious Disease Unit, where standard precautions are handled (favorable architecture and appropriate practice for hand hygiene), assessment of contact precautions to reduce the incidence of acquired bacteria during hospitalization would be of interest.

The investigators design a non-inferiority comparative study to measure the colonization pressure in patients hospitalized in two different parts of the department: one unit only with standard precautions applied (intervention) and one unit with contact precautions (control) as current routine care.


Recruitment information / eligibility

Status Terminated
Enrollment 400
Est. completion date June 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient hospitalized in Infectious Diseases Unit during the study period in one of the selected part of the unit participating to the study

- Patient informed about the study protocol and approved to participate.

Exclusion Criteria:

- Patient requiring isolation prescription type "air" or "droplet"

- Patient hospitalized in the central sector of the building (including 4 bedrooms in depression negative service)

- Patient colonized with bacteria producing carbapenemase, multi-resistant Acinetobacter baumanii or Vancomycin-Resistant Enterococcus.

- Patients under legal protection (juridical protection, legal guardianship) or persons on juridical detention.

Study Design

Observational Model: Case-Crossover, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France Rennes University Hospital Rennes Brittany

Sponsors (1)

Lead Sponsor Collaborator
Rennes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acquisition rate of micro-organisms Acquisition rate using bacteriological sampling (nose and anus) at admission and at the day of discharge in each patient hospitalized in the department. 2 years No
Secondary Number of infections acquired during hospitalization in each group 2 years No
Secondary Consumption of hydro-alcoholic rub in each group 2 years No
Secondary Utilization of aprons and gloves in each group 2 years No